Alan Schwebel - Bio View CEO and Pres

BIOV Stock  ILS 29.00  0.70  2.36%   

CEO

Dr. Alan Schwebel serves as Chief Executive Officer and Director at Bio View Ltd since March 19, 2009. Previously, he served as Vice President of Sales and Marketing at the Company from May 12, 2002 until March 19, 2009. Dr. Schwebel has more than 20 years of experience in senior management positions in Medical Device and Medical Diagnostic Companies. Prior to joining the Company, he served as President of Mennen Medical Ltd., a medical device company since 2009.
Age 69
Tenure 15 years
Professional MarksPh.D
Phone972 73 227 1025
Webhttps://www.bioview.com
Schwebel holds a Doctorate of Science degree in Chemistry from City University of New York and a B.Sc. degree in Chemistry from the City University of New York at Brooklyn College.

Bio View Management Efficiency

Bio View's management efficiency ratios could be used to measure how well Bio View manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.57 M in total debt with debt to equity ratio (D/E) of 11.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Bio-View has a current ratio of 2.1, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Bio View until it has trouble settling it off, either with new capital or with free cash flow. So, Bio View's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bio-View sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bio to invest in growth at high rates of return. When we think about Bio View's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 5 records

CEO Age

Ami BarlevB Communications
40
Arie AmirHiron Trade Investments Industr
77
Dan RoznerHiron Trade Investments Industr
81
Ron OrenRapac Communication Infrastruct
51
Doron TurgemanB Communications
49
BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel. Bio View (BIOV) is traded on Tel Aviv Stock Exchange in Israel and employs 35 people.

Management Performance

Bio-View Leadership Team

Elected by the shareholders, the Bio View's board of directors comprises two types of representatives: Bio View inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bio. The board's role is to monitor Bio View's management team and ensure that shareholders' interests are well served. Bio View's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bio View's outside directors are responsible for providing unbiased perspectives on the board's policies.
Elad Kfir, Vice President of Marketing
Eliane Markowitz, External Director
Yuval Harari, Co-CEO, Director
Emmanuel Gill, Chairman of the Board
David Kutas, CEO of BioView Inc - USA and President of BioView Inc - USA
Yacha Sutton, Director
Marina Wolfson, CFO
Alan Schwebel, CEO and Pres
Jackie RosenblumGoren, External Director
Yulia CPA, Chief Officer
Inbal Hillel, Vice President - Operations
Lior Shav, Director
Yuval MSc, Ex VP
Eliyahu AyalonLanciano, External Director
Warren Esanu, Director

Bio Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bio View a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bio View in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bio View's short interest history, or implied volatility extrapolated from Bio View options trading.

Pair Trading with Bio View

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio View position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio View will appreciate offsetting losses from the drop in the long position's value.

Moving against Bio Stock

  0.49JBNK JerusalemPairCorr
  0.41MTDS Meitav Dash InvestmentsPairCorr
The ability to find closely correlated positions to Bio View could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio View when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio View - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio View to buy it.
The correlation of Bio View is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio View moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio-View moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio View can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio View. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Bio Stock analysis

When running Bio View's price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Please note, there is a significant difference between Bio View's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio View is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio View's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.